---
figid: PMC9414081__fnut-09-952147-g0010
figtitle: Research progress on extraction technology and biomedical function of natural
  sugar substitutes
organisms:
- Saccharomyces cerevisiae
- Oryza sativa
- PX clade
- Panax ginseng
- Agaricus bisporus
- Theobroma cacao
- Pyrus communis
- Beta vulgaris subsp. vulgaris
- Avena sativa
- Glycyrrhiza uralensis
- Glycyrrhiza glabra
- Stevia rebaudiana
- Citrus maxima
- Cinnamomum camphora
- Clavispora lusitaniae
- Moesziomyces antarcticus
- Siraitia grosvenorii
- Artocarpus heterophyllus
- Smallanthus sonchifolius
- Dioscoreophyllum cumminsii
- Pentadiplandra brazzeana
- Sorbus tianschanica
- Escherichia coli
- Staphylococcus aureus
- Enterococcus faecalis
- Bacillus anthracis
- Streptococcus mutans
- Zymomonas mobilis
- Escherichia coli SCD1
- Arthrobacter globiformis
- Pseudomonas cichorii
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Sapajus apella
- gut metagenome
- Opsanus beta
- synthetic gene
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Sapajus apella
- Drosophila melanogaster
pmcid: PMC9414081
filename: fnut-09-952147-g0010.jpg
figlink: /pmc/articles/PMC9414081/figure/F10/
number: F10
caption: The mechanism of stevia glycoside in hypoglycemic, anti-inflammatory, and
  hypolipidemic. (A) Stevia glycoside binds to sweet receptors (T1R2–T1R3 dimer),
  prompting the endoplasmic reticulum to release Ca2+. Ca2+ opens the transient receptor
  potential ion channel protein 5 (TRPM5), allowing Na+ to enter and generate action
  potentials. At the same time, glucose is transferred to the mitochondria by enhanced
  diffusion of glucose transporter to generate ATP, which inhibits the opening of
  the ATP-sensitive potassium (KATP) and increases action potential production. Finally,
  the action potential opens the voltage-dependent calcium channel (VDCC), which allows
  Ca2+ to flow in. Thus, an increase in Ca2+ in β cells stimulates insulin secretion
  and hypoglycemia. (B) Stevia glycoside reduces the inflammatory factors IL-1β And
  IL-6 production, as well as the phosphorylation of two critical MAPK pathway proteins,
  p38 and ERK, as well as decreased TNF-α expression and hence NF-κB activation, all
  of which contribute to inflammation resistance. (C) Stevia glycoside decreases intracellular
  cholesterol by inhibiting HMGCR expression, the rate-limiting enzyme in the de novo
  cholesterol synthesis pathway, while increasing the cell surface LDL binding receptor
  (LDLR), promoting cholesterol breakdown in the cell, and the LDLR returns to the
  cell surface, resulting in hypolipidemia.
papertitle: Research progress on extraction technology and biomedical function of
  natural sugar substitutes.
reftext: Pengyu Lei, et al. Front Nutr. 2022;9:952147.
year: '2022'
doi: 10.3389/fnut.2022.952147
journal_title: Frontiers in Nutrition
journal_nlm_ta: Front Nutr
publisher_name: Frontiers Media S.A.
keywords: natural sugar substitutes | extraction technology | inflammation | obesity
  | diabetes
automl_pathway: 0.8752207
figid_alias: PMC9414081__F10
figtype: Figure
redirect_from: /figures/PMC9414081__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9414081__fnut-09-952147-g0010.html
  '@type': Dataset
  description: The mechanism of stevia glycoside in hypoglycemic, anti-inflammatory,
    and hypolipidemic. (A) Stevia glycoside binds to sweet receptors (T1R2–T1R3 dimer),
    prompting the endoplasmic reticulum to release Ca2+. Ca2+ opens the transient
    receptor potential ion channel protein 5 (TRPM5), allowing Na+ to enter and generate
    action potentials. At the same time, glucose is transferred to the mitochondria
    by enhanced diffusion of glucose transporter to generate ATP, which inhibits the
    opening of the ATP-sensitive potassium (KATP) and increases action potential production.
    Finally, the action potential opens the voltage-dependent calcium channel (VDCC),
    which allows Ca2+ to flow in. Thus, an increase in Ca2+ in β cells stimulates
    insulin secretion and hypoglycemia. (B) Stevia glycoside reduces the inflammatory
    factors IL-1β And IL-6 production, as well as the phosphorylation of two critical
    MAPK pathway proteins, p38 and ERK, as well as decreased TNF-α expression and
    hence NF-κB activation, all of which contribute to inflammation resistance. (C)
    Stevia glycoside decreases intracellular cholesterol by inhibiting HMGCR expression,
    the rate-limiting enzyme in the de novo cholesterol synthesis pathway, while increasing
    the cell surface LDL binding receptor (LDLR), promoting cholesterol breakdown
    in the cell, and the LDLR returns to the cell surface, resulting in hypolipidemia.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HMGCR
  - LDLR
  - TRPM5
  - ATP8A2
  - SLC2A1
  - TNF
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - SGSM3
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - Hmgcr
  - Ldlr
  - Trpm5
  - Slc1a3
  - Tnf
  - Nfkb1
  - Ephb2
  - Mapk1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Lipa
  - Gls
  - Ephb1
  - modSP
  - de
  - LRP1
  - LpR2
  - mgl
  - na
  - ATPsynbeta
  - Atpalpha
  - Eaat1
  - Glut1
  - Glut4EF
  - Glut3
  - egr
  - Dif
  - dl
  - Rel
  - Erk7
  - rl
  - mapP
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
